Related Experiment Videos
Wegener's granulomatosis in an 11-year-old child. A case report
D Mohanlal1, K E Meyers, I van Niekerk
1Department of Paediatrics and Child Health, Coronation Hospital, Johannesburg.
Insights
Early diagnosis and treatment of Wegener's granulomatosis (WG) using cyclophosphamide significantly improves patient outcomes. This report details a case study of an 11-year-old child diagnosed and treated for WG.
Area of Science:
- Rheumatology
- Pediatric Medicine
- Immunology
Background:
- Wegener's granulomatosis (WG) is a rare, previously fatal autoimmune vasculitis.
- Early intervention is critical for managing WG and improving prognosis.
Observation:
- This study reports on the experience with WG in an 11-year-old child.
- The case highlights the challenges and successes of managing pediatric WG.
Findings:
- Early diagnosis and prompt treatment with cyclophosphamide led to a significantly improved prognosis.
- Cyclophosphamide demonstrated efficacy in managing the disease in a pediatric patient.
Implications:
- Early diagnosis and cyclophosphamide treatment are crucial for improving outcomes in pediatric WG.
- This case contributes to the understanding of WG management in children.
- Further research into pediatric WG is warranted to optimize treatment strategies.
Abstract:
Early diagnosis and treatment of Wegener's granulomatosis with cyclophosphamide has considerably improved the prognosis in this previously fatal disease. Experience with this disease in an 11-year-old child is reported.